Dudediligence.

Pelthos Therapeutics Inc

PTHSAMEX · Biological Products, (No Diagnostic Substances)
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$0.00Mar ’25$7.4MSep ’25$9.4MDec ’25$10.9MMar ’26$15.6MJun ’26
Net income, by quarter
−$1.7MSep ’24−$1.9MDec ’24−$2.0MMar ’25−$3.4MJun ’25−$16.2MSep ’25−$21.7MDec ’25−$25.1MMar ’26−$23.4MJun ’26
Fiscal years, by the month each ended
LineDec 2022Dec 2023Dec 2024Dec 2025
Revenuenone on filenone on file$0.00$16.8M
Gross profitnone on filenone on file$0.00$12.8M
Operating income−$2.3M−$6.9M−$7.6M−$32.4M
Net income−$2.5M−$7.4M−$8.0M−$43.3M
Operating cash flow−$1.6M−$981,031−$5.8M−$22.6M
Free cash flownone on filenone on file−$5.8M−$22.7M
Cash$55,074$96,391$513,000$18.0M
Shares outstanding1.1M3.9M610.4K3.2M